US Navy cancels MASC programme, launches $2.1bn MUSV marketplace as the Golden Fleet strategy moves from concept to procurement
No Kings protests return to New York City for third time as nationwide mobilisation targets Trump administration policies
Read More 5 minute read Pharma Industry News BioNTech stock jumps 8.66% after DB-1303 meets primary endpoint in breast cancer trial BioNTech stock surged after DB-1303 met its Phase 3 endpoint in HER2-positive breast cancer. Find out what this means for global oncology strategy. byPallavi MadhirajuSeptember 6, 2025